Literature DB >> 12703472

[Pegasys: FDA approved Pegasys (peginterferon alfa-2a) for the treatment of hepatitis C].

Mauricio Iafolla.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12703472

Source DB:  PubMed          Journal:  Sidahora


× No keyword cloud information.
  2 in total

1.  Peginterferon plus Chinese herbal therapy is associated with a higher virological response than only peginterferon therapy in chronic hepatitis C.

Authors:  D Cheng; E Liu; Y Li; R Liu; L Bai; Y Chen; Y Wang; Y Chu; M Wu; G Cheng; S Zhao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03       Impact factor: 3.267

2.  Treatment with peginterferon versus interferon in Chinese patients with chronic hepatitis C.

Authors:  S Zhao; E Liu; K Wei; Y Wang; Y Li; B Huang; Y Chen; P Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-09       Impact factor: 3.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.